- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- Colon
- Hepatobiliary
- Lower GI
- Upper GI
Offers
- Face-to-face consultations
- Home chemotherapy
About me
Dr Gaya qualified at St George’s (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London. He has been a consultant clinical oncologist at Guy's and St Thomas' Hospitals for 15 years.
Dr Gaya treats all gastrointestinal tumours (e.g. oesophagus, stomach, liver, pancreas, colon, rectum, anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. Dr Gaya’s main interests are in the areas of functional cancer imaging (Kings College, London), and combining immunotherapy with radiation treatment.
He is heavily involved with the implementation and usage of the latest radiotherapy techniques such as MRI guided radiotherapy (MRIdian - https://www.genesiscare.com/uk/mrl-hcp/), proton therapy and stereotactic body radiosurgery (gamma knife, cyberknife). He has published and peer-reviewed widely for international journals (https://www.ncbi.nlm.nih.gov/pubmed/?term=Gaya+A). He is an active member of ASTRO (https://www.astro.org/), the Radiosurgery Society (http://therss.org/) and the International Stereotactic Radiosurgery Society (http://www.isrsy.org/en/). Dr Gaya is also interested in the introduction of advanced technology such as AI and machine learning to medicine and is a big supporter of Exponential Medicine (https://exponential.singularityu.org/medicine/) and the Singularity University programs.
Â
Offering both drug-based and radiation-based therapies and close liaison with surgical and interventional radiology, he is a leading authority on the unique combination of multiple treatment modalities and personalised tumour molecular profiling into a treatment package for each patient.
Areas of interest
Chemotherapy; Radiotherapy; Biological Therapies; Cyberknife; Immunotherapy; Personalised Medicine; advanced radiotherapy; proton radiotherapy; MRI guided radiotherapy; SABR; stereotactic radiotherapy;
Gastrointestinal Malignancies; Oesophagus; Stomach (gastric); Pancreas; Liver; Biliary; Colon; Rectum; Anus; Neuroendocrine; GIST; Cancer of Unknown Primary;
Medical secretaries
- Danielle Thornton
- 4th Floor 116 Harley Street London W1G 7JL
- 020 7034 6160
- gayaPAs@thelondonclinic.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)
London Clinic (5-50) Cromwell Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
London Clinic (5-50) Cromwell Hospital (5-50) GenesisCare, Cromwell Hospital (1-5)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (>50)
London Clinic (5-50) GenesisCare, Cromwell Hospital (5-50) Cromwell Hospital (1-5)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
London Clinic (5-50) GenesisCare, Cromwell Hospital (1-5)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
London Clinic (5-50)
- Show All (14 )...